EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

PGII Higher than PGI: a Case Analysis and Literature Review

Hong-Gang Sun, Ke-Jie Xie, Li-Qin He

Clinical Laboratory · 2025

DOI: 10.7754/clin.lab.2024.241104 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Laboratory, 2025. Verfasst von Hong-Gang Sun und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Pepsinogen A, Pepsinogen C, Stomach Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Serum pepsinogen (PG) testing, including PGI and PGII, is widely used for early screening, diagnosis, and prognostic assessment of gastric cancer. PGI mainly reflects the state of the gastric corpus mucosa, while PGII mainly reflects the state of the gastric fundus mucosa. The levels of PGI and PGII can reflect the degree of gastric mucosal atrophy, and when gastric mucosal lesions occur, the content of PGI and PGII in the serum will also change. In gastric cancer screening, serum pepsinogens can be used to judge the patient's condition through changes in PGI, PGII, and the PGI/PGII index, which is considered as "serological gastroscopy". METHODS: Chemiluminescence assay was used to detect serum pepsinogen I (PGI) and pepsinogen II (PGII) and to explore their clinical value before and after treatment. RESULTS: The PGI was measured at 89.45 ng/mL (reference range 70 - 240 ng/mL), PGII at 505.4 ng/mL (reference range 0 - 13 ng/mL), and PGR PGI/II at 0.18 (reference range greater than 3). The patient underwent endoscopic local surgery and two weeks later, the PGI was measured at 56.53 ng/mL, PGII at 81.58 ng/mL, and PGR PGI/II at 0.69. The PGI and PGII measurement method was Mindray (Shenzhen, China) chemiluminescence assay. The patient's endoscopic biopsy report indicated precancerous gastric lesions. CONCLUSIONS: For the 70-year-old male patient mentioned in the document, the test results of PGI and PGII, as well as the PGR value, all suggest the risk of precancerous gastric lesions. After treatment, although PGI and PGII decreased, PGII is still higher than PGI, and PGR has improved, indicating that the patient still has the possibility of cancer development and requires further endoscopic examination and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pepsinogen APepsinogen CStomach NeoplasmsAgedHumansMaleGastric MucosaGastroscopyLuminescent Measurements

Substanzen

Pepsinogen APepsinogen C

Zitieren

APA

Sun, H. G., Xie, K. J., & He, L. Q. (2025). PGII Higher than PGI: a Case Analysis and Literature Review. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2024.241104

Vancouver

Sun HG, Xie KJ, He LQ. PGII Higher than PGI: a Case Analysis and Literature Review. Clinical Laboratory. 2025. doi:10.7754/clin.lab.2024.241104

BibTeX
@article{Sun2025,
  author = {Sun, Hong-Gang and Xie, Ke-Jie and He, Li-Qin},
  title = {PGII Higher than PGI: a Case Analysis and Literature Review},
  journal = {Clinical Laboratory},
  year = {2025},
  doi = {10.7754/clin.lab.2024.241104}
}
Kostenlos starten →